Allarity Therapeutics (ALLR) EBT (2020 - 2026)
Allarity Therapeutics' (ALLR) quarterly EBT came in at -$2.8 million in Q1 2026, down 0.81% YoY from -$2.8 million in Q1 2025, and up 18.35% on a QoQ basis from -$3.4 million in Q4 2025.
Allarity Therapeutics (ALLR) EBT (2020 - 2026) Analysis & Trends
Allarity Therapeutics (ALLR) has 7 years of EBT data on file, last reported at -$2.8 million in Q1 2026.
- Quarterly EBT fell 0.81% year-over-year to -$2.8 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$11.3 million (down 51.96% YoY) and the FY2025 annual result came in at -$11.2 million, down 31.82% from the prior year.
- EBT advanced to -$2.8 million in Q1 2026, from -$3.4 million in the prior quarter.
- In the past five years, EBT ranged from a high of $8.9 million in Q4 2024 to a low of -$12.0 million in Q3 2024.
- A 5-year average of -$3.1 million and a median of -$3.1 million in 2022 frame the typical range for EBT.
- Annual changes were most pronounced in 2022 — EBT tumbled 282.37% — and 2024, when it soared 644.42%.
- Tracing ALLR's EBT over 5 years: stood at -$3.1 million in 2022, then soared by 47.82% to -$1.6 million in 2023, then soared by 644.42% to $8.9 million in 2024, then tumbled by 137.8% to -$3.4 million in 2025, then climbed by 18.35% to -$2.8 million in 2026.
- The last three EBT figures came in at -$2.8 million (Q1 2026), -$3.4 million (Q4 2025), and -$2.8 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | 1.39 Bn |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | 1.53 Bn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | 541.00 Mn |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | -767.00 Mn |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 312.46 Mn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | 177.81 Mn |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | -11.37 Mn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | 81.49 Mn |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | -264.70 Mn |
| 10 | Allarity Therapeutics | 23.23 Mn | 23.23 Mn | - | -3.17 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -2.75 Mn |
| Dec 31, 2025 | -3.37 Mn |
| Sep 30, 2025 | -2.81 Mn |
| Jun 30, 2025 | -2.32 Mn |
| Mar 31, 2025 | -2.73 Mn |
| Dec 31, 2024 | 8.92 Mn |
| Sep 30, 2024 | -11.97 Mn |
| Jun 30, 2024 | -1.63 Mn |
| Mar 31, 2024 | -3.85 Mn |
| Dec 31, 2023 | -1.64 Mn |
| Sep 30, 2023 | -4.45 Mn |
| Jun 30, 2023 | -2.38 Mn |
| Mar 31, 2023 | -3.35 Mn |
| Dec 31, 2022 | -3.14 Mn |
| Sep 30, 2022 | -5.03 Mn |
| Jun 30, 2022 | -5.10 Mn |
| Mar 31, 2022 | -4.31 Mn |
| Dec 31, 2021 | -16.78 Mn |
| Sep 30, 2021 | -1.32 Mn |
| Jun 30, 2021 | -5.37 Mn |